Applied DNA Sciences Inc.

2.12
0.33 (18.44%)
At close: Mar 24, 2025, 3:59 PM
2.23
5.23%
Pre-market: Mar 25, 2025, 09:13 AM EDT

Applied DNA Sciences Statistics

Share Statistics

Applied DNA Sciences has 1.1M shares outstanding. The number of shares has increased by 208% in one year.

Shares Outstanding 1.1M
Shares Change (YoY) 208%
Shares Change (QoQ) 407.74%
Owned by Institutions (%) 0.08%
Shares Floating 1.03M
Failed to Deliver (FTD) Shares 6.76K
FTD / Avg. Volume 1.18%

Short Selling Information

The latest short interest is 1.77M, so 3.21% of the outstanding shares have been sold short.

Short Interest 1.77M
Short % of Shares Out 3.21%
Short % of Float 3.22%
Short Ratio (days to cover) 0.47

Valuation Ratios

The PE ratio is -18.43 and the forward PE ratio is -0.18. Applied DNA Sciences's PEG ratio is 0.21.

PE Ratio -18.43
Forward PE -0.18
PS Ratio 37.55
Forward PS 0.3
PB Ratio 14.09
P/FCF Ratio -9.13
PEG Ratio 0.21
Financial Ratio History

Enterprise Valuation

Applied DNA Sciences Inc. has an Enterprise Value (EV) of 310.51M.

EV / Earnings -44.41
EV / Sales 90.49
EV / EBITDA -22.14
EV / EBIT -22.14
EV / FCF -21.99

Financial Position

The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.08.

Current Ratio 3.36
Quick Ratio 3.17
Debt / Equity 0.08
Total Debt / Capitalization 7.48
Cash Flow / Debt -18.55
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.76% and return on capital (ROIC) is -147.28%.

Return on Equity (ROE) -0.76%
Return on Assets (ROA) -0.55%
Return on Capital (ROIC) -147.28%
Revenue Per Employee $74,596.09
Profits Per Employee $-152,011.33
Employee Count 46
Asset Turnover 0.27
Inventory Turnover 5.51

Taxes

Income Tax 137.3K
Effective Tax Rate -0.02

Stock Price Statistics

The stock price has increased by -99.56% in the last 52 weeks. The beta is 0.42, so Applied DNA Sciences's price volatility has been higher than the market average.

Beta 0.42
52-Week Price Change -99.56%
50-Day Moving Average 7.23
200-Day Moving Average 22.86
Relative Strength Index (RSI) 23.69
Average Volume (20 Days) 572.65K

Income Statement

In the last 12 months, Applied DNA Sciences had revenue of 3.43M and earned -6.99M in profits. Earnings per share was -1.76.

Revenue 3.43M
Gross Profit 1.02M
Operating Income -14.02M
Net Income -6.99M
EBITDA -14.02M
EBIT -14.02M
Earnings Per Share (EPS) -1.76
Full Income Statement

Balance Sheet

The company has 6.43M in cash and 739.16K in debt, giving a net cash position of 5.69M.

Cash & Cash Equivalents 6.43M
Total Debt 739.16K
Net Cash 5.69M
Retained Earnings -309.67M
Total Assets 15.97M
Working Capital 8.89M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.71M and capital expenditures -407.9K, giving a free cash flow of -14.12M.

Operating Cash Flow -13.71M
Capital Expenditures -407.9K
Free Cash Flow -14.12M
FCF Per Share -3.56
Full Cash Flow Statement

Margins

Gross margin is 29.63%, with operating and profit margins of -408.72% and -203.78%.

Gross Margin 29.63%
Operating Margin -408.72%
Pretax Margin -206.57%
Profit Margin -203.78%
EBITDA Margin -408.72%
EBIT Margin -408.72%
FCF Margin -411.47%

Dividends & Yields

APDN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -83.02%
FCF Yield -603.39%
Dividend Details

Analyst Forecast

The average price target for APDN is $75, which is 3437.7% higher than the current price. The consensus rating is "Buy".

Price Target $75
Price Target Difference 3437.7%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Mar 14, 2025. It was a backward split with a ratio of 1:50.

Last Split Date Mar 14, 2025
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score -30.16
Piotroski F-Score 3